Multimodal targeting chimeras enable integrated immunotherapy leveraging tumor-immune microenvironment.
Lin F, Yin S, Zhang Z, Yu Y, Fang H, Liang Z, Zhu R, Zhou H, Li J, Cao K, Guo W, Qin S, Zhang Y, Lu C, Li H, Liu S, Zhang H, Ye B, Lin J, Li Y, Kang X, Xi JJ, Chen PR.
Lin F, et al. Among authors: zhang z, zhang h, zhang y.
Cell. 2024 Dec 26;187(26):7470-7491.e32. doi: 10.1016/j.cell.2024.10.016. Epub 2024 Nov 5.
Cell. 2024.
PMID: 39504957